Compare Supplements

Side-by-side comparison of 1 supplements

Crb4.0

Cerebrolysin

Limited safety

Evidence

Evidence Score4/10

Studies: 11

Meta-analyses: 8

Dosage & timing

Dosage:

Trial regimens vary widely (e.g. 30 mL/day IV for 10-21 days in stroke/dementia; intramuscular injection at lower doses). No validated optimal dose; this is a prescription drug abroad, not a self-administered supplement.

Best Time:

Morning

Can take on empty stomach

Form:

Injectable solution (clinician-administered, where approved)

What you'll notice

➖ Acute stroke: no proven benefit (Cochrane-null)neutral

Weeks (during/after treatment course)

⚠️ Possible harm: non-fatal serious adverse eventstrade-off

During treatment

🧠 Vascular dementia: weak, low-quality signalneutral

Weeks to months

Safety

Limited safety

Contraindications:

Known hypersensitivity to the product (porcine-derived biological)
Severe renal impairment (status epilepticus and epilepsy are listed cautions in product labelling)
Pregnancy / breastfeeding (not adequately studied)

Drug Interactions:

Antidepressants (MAO inhibitors)
Other amino-acid-containing infusions

Side Effects:

Non-fatal serious adverse events (acute stroke setting)Injection-site reactionsAgitation / feeling hot / sweating / dizziness

Want to compare more supplements?

Loading comparison...